Global HIV and TB
Global HIV and TB Response
HIV and tuberculosis (TB) are the world’s two most deadly infectious diseases. Additionally, these two epidemics are tragically interconnected, as TB is the leading cause of death for those living with HIV.
CDC’s Division of Global HIV & TB, through the U.S. President’s Emergency Plan for AIDS Reliefexternal icon, is tackling these two epidemics to produce the greatest impact. Our experts are working on the front lines in more than 45 countries and regions around the globe, focused on a single mission: to fight these diseases and, ultimately, bring an end to the dual epidemics of HIV and TB worldwide.
Worldwide, HIV and TB are a deadly combination.
CDC and partners are making a powerful impact
against these two diseases.
*Other USG agencies may have also contributed
**As of Sept 30, 2019
***FY2019 | ****Cumulative through Sept 30, 2019
Men have received voluntary medical circumcision procedures****
People who received a positive HIV test result***
Men, women and children who have received life-saving HIV treatment**
Screened in Care for TB****
Women who were treated to help reduce
risk of mother-to-child HIV transmission***
Antiretroviral Treatment for Men, Women, and Children**
PEPFAR: 15.7 Million
CDC: 9.2 Million
Voluntary Medical Male Circumcisions (VMMC)****
PEPFAR: 22.9 Million
CDC: 11.5 Million
People Who Received a
Positive HIV Test Result***
PEPFAR: 3 Million
CDC: 1.7 Million
HIV-Positive Persons Screened in Care for TB***
PEPFAR: 11.7 Million
CDC: 6.8 Million
Antiretroviral Treatment to Prevent Mother-to-child Transmission***
*Other USG agencies may have also contributed to some of these achievements **As of Sept 30, 2019 ***FY2019 ****Cumulative through Sept 30, 2019